P G Pappas

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. pmc Cryptococcal infections in non-HIV-infected patients
    Peter G Pappas
    Division of Infectious Diseases, University of Alabama at Birmingham, 1900 University Blvd, 229 THT, Birmingham, AL 35294 0006, USA
    Trans Am Clin Climatol Assoc 124:61-79. 2013
  2. pmc Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
    Annette C Reboli
    Division of Infectious Diseases, Cooper Medical School of Rowan University, 2 Aquarium Drive, Suite 305, Camden, NJ 08103, USA
    BMC Infect Dis 11:261. 2011
  3. ncbi request reprint Immunotherapy for invasive fungal infections: from bench to bedside
    Peter G Pappas
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine, 1900 University Boulevard, 229 THT, Birmingham, AL 35294 0006, USA
    Drug Resist Updat 7:3-10. 2004
  4. ncbi request reprint Guidelines for treatment of candidiasis
    Peter G Pappas
    Division of Infectious Diseases, University of Alabama at Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 38:161-89. 2004
  5. ncbi request reprint Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis
    Peter G Pappas
    University of Alabama School of Medicine, Birmingham, Alabama 35294 0006, USA
    J Infect Dis 189:2185-91. 2004
  6. doi request reprint Opportunistic fungi: a view to the future
    Peter G Pappas
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294 0006, USA
    Am J Med Sci 340:253-7. 2010
  7. ncbi request reprint A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
    Peter G Pappas
    University of Alabama at Birmingham, 35294 0006, USA
    Clin Infect Dis 37:634-43. 2003
  8. doi request reprint Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
    Peter G Pappas
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 50:1101-11. 2010
  9. ncbi request reprint Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry
    Peter G Pappas
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL 35294, USA
    Clin Infect Dis 40:S379-83. 2005
  10. ncbi request reprint Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study
    P G Pappas
    University of Alabama at Birmingham Medical Center, Madison, WI
    Am J Transplant 6:386-91. 2006

Research Grants

Detail Information

Publications51

  1. pmc Cryptococcal infections in non-HIV-infected patients
    Peter G Pappas
    Division of Infectious Diseases, University of Alabama at Birmingham, 1900 University Blvd, 229 THT, Birmingham, AL 35294 0006, USA
    Trans Am Clin Climatol Assoc 124:61-79. 2013
    ....
  2. pmc Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome
    Annette C Reboli
    Division of Infectious Diseases, Cooper Medical School of Rowan University, 2 Aquarium Drive, Suite 305, Camden, NJ 08103, USA
    BMC Infect Dis 11:261. 2011
    ..We sought to better understand the factors associated with the enhanced efficacy of anidulafungin and hypothesized that intrinsic properties of the antifungal agents contributed to the treatment differences...
  3. ncbi request reprint Immunotherapy for invasive fungal infections: from bench to bedside
    Peter G Pappas
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham School of Medicine, 1900 University Boulevard, 229 THT, Birmingham, AL 35294 0006, USA
    Drug Resist Updat 7:3-10. 2004
    ..There are several obstacles preventing the conduct of these studies, but these pressing clinical issues must be addressed through carefully considered study design and effective implementation...
  4. ncbi request reprint Guidelines for treatment of candidiasis
    Peter G Pappas
    Division of Infectious Diseases, University of Alabama at Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 38:161-89. 2004
  5. ncbi request reprint Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis
    Peter G Pappas
    University of Alabama School of Medicine, Birmingham, Alabama 35294 0006, USA
    J Infect Dis 189:2185-91. 2004
    ..Adjunctive therapy with rIFN- gamma 1b holds promise for patients with acute cryptococcal meningitis and warrants further study...
  6. doi request reprint Opportunistic fungi: a view to the future
    Peter G Pappas
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294 0006, USA
    Am J Med Sci 340:253-7. 2010
    ..Newer azoles, including posaconazole, isavuconazole and ravuconazole, will potentially provide more effective therapeutic options in the future, diminishing the role for amphotericin B...
  7. ncbi request reprint A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients
    Peter G Pappas
    University of Alabama at Birmingham, 35294 0006, USA
    Clin Infect Dis 37:634-43. 2003
    ..6 vs. 16.1), which suggests that the former subjects are more often excluded from therapeutic trials...
  8. doi request reprint Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
    Peter G Pappas
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham Medical Center, Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 50:1101-11. 2010
    ..Invasive fungal infections (IFIs) are a major cause of morbidity and mortality among organ transplant recipients. Multicenter prospective surveillance data to determine disease burden and secular trends are lacking...
  9. ncbi request reprint Amphotericin B lipid complex in the treatment of invasive fungal infections: results of the Collaborative Exchange of Antifungal Research (CLEAR), an industry-supported patient registry
    Peter G Pappas
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL 35294, USA
    Clin Infect Dis 40:S379-83. 2005
  10. ncbi request reprint Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study
    P G Pappas
    University of Alabama at Birmingham Medical Center, Madison, WI
    Am J Transplant 6:386-91. 2006
    ..Liver transplant recipients at low risk for IFI can be identified utilizing pre-determined criteria, and post-transplantation antifungal prophylaxis can be routinely withheld in these patients...
  11. doi request reprint Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
    Peter G Pappas
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294 0006, USA
    Clin Infect Dis 48:503-35. 2009
    ..This new information is incorporated into this revised document...
  12. doi request reprint A phase II randomized trial of amphotericin B alone or combined with fluconazole in the treatment of HIV-associated cryptococcal meningitis
    Peter G Pappas
    Div of Infectious Diseases, University of Alabama at Birmingham Medical Center, 1900 University Blvd, THT 229, Birmingham, AL 35294 0006, USA
    Clin Infect Dis 48:1775-83. 2009
    ..Therapeutic options for the treatment of central nervous system cryptococcosis are limited, especially in resource-limited settings...
  13. ncbi request reprint Invasive candidiasis
    Peter G Pappas
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, AL 35294 0006, USA
    Infect Dis Clin North Am 20:485-506. 2006
    ..Research that focuses on these important clinical areas could provide valuable insights into the diagnosis and management of this common and evolving infection...
  14. ncbi request reprint Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
    Peter G Pappas
    Div of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    Clin Infect Dis 45:883-93. 2007
    ..The echinocandins have potent fungicidal activity against most Candida species, but there are few data comparing the safety and efficacy of echinocandins in the treatment of invasive candidiasis...
  15. ncbi request reprint Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy
    P G Pappas
    University of Alabama at Birmingham Medical Center, Birmingham, AL 35294 0006, USA
    Clin Infect Dis 33:690-9. 2001
    ..Overall mortality was 30%, and mortality attributable to cryptococcosis was 12%. Cryptococcosis continues to be an important infection in HIV-negative patients and is associated with substantial overall and cause-specific mortality...
  16. pmc Microascus cinereus (Anamorph scopulariopsis) brain abscess in a bone marrow transplant recipient
    J W Baddley
    University of Alabama at Birmingham, Birmingham, Alabama, USA
    J Clin Microbiol 38:395-7. 2000
    ..The patient responded well to treatment by amphotericin B lipid complex, itraconazole, and a craniotomy but later died from secondary complications caused by graft-versus-host disease...
  17. ncbi request reprint A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects
    John H Rex
    Division of Infectious Diseases, University of Texas Medical School, Houston, TX 77030, USA
    Clin Infect Dis 36:1221-8. 2003
    ..02). In nonneutropenic subjects, the combination of fluconazole plus AmB was not antagonistic compared with fluconazole alone, and the combination trended toward improved success and more-rapid clearance from the bloodstream...
  18. ncbi request reprint Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America
    S W Chapman
    Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS 39216 4505, USA
    Clin Infect Dis 30:679-83. 2000
    ..Although there are no comparative trials, itraconazole appears more efficacious than either ketoconazole or fluconazole. Thus, itraconazole is the initial treatment of choice for nonlife-threatening non-CNS blastomycosis...
  19. ncbi request reprint Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital
    J W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Diagn Microbiol Infect Dis 39:199-201. 2001
    ..The frequency of C. glabrata isolates among all blood culture isolates of Candida spp. causing bloodstream infection remained stable during the study period and ranged from 18-31%...
  20. ncbi request reprint Antifungal combination therapy: clinical potential
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, and Birmingham Veteran s Administration Medical Center, Birmingham, Alabama 35294 0006, USA
    Drugs 65:1461-80. 2005
    ..Ultimately, the goal is to provide the reader with a comprehensive but useful review to this complicated and often confusing therapeutic dilemma...
  21. pmc Pneumocystis pneumonia in hospitalized patients: a detailed examination of symptoms, management, and outcomes in human immunodeficiency virus (HIV)-infected and HIV-uninfected persons
    J A McKinnell
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA
    Transpl Infect Dis 14:510-8. 2012
    ..We postulated that prevention and inpatient management of HIV-PCP differed from NH-PCP...
  22. ncbi request reprint Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America
    M S Saag
    University of Alabama at Birmingham, 35294 2050, USA For the Mycoses Study Group Cryptococcal Subproject
    Clin Infect Dis 30:710-8. 2000
    ..In all cases of cryptococcal meningitis, careful attention to the management of intracranial pressure is imperative to assure optimal c..
  23. pmc Factors associated with mortality in transplant patients with invasive aspergillosis
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, AL 35294 0006, USA
    Clin Infect Dis 50:1559-67. 2010
    ..The purpose of this study was to evaluate factors associated with mortality in transplant patients with IA...
  24. pmc Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    J Clin Microbiol 47:3271-5. 2009
    ..61; P = 0.065). Significant relationships of in vitro MIC to all-cause mortality at 6 and 12 weeks for VOR or AMB were not found...
  25. doi request reprint Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy
    John W Baddley
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    Diagn Microbiol Infect Dis 62:151-6. 2008
    ..8-0.98; P=0.02) were independent predictors of poor prognosis. Histoplasmosis in HIV patients is associated with poor outcomes. Identification of prognostic factors may be helpful in identifying patients who require more aggressive care...
  26. ncbi request reprint Cryptococcal meningitis: current approaches to management in patients with and without AIDS
    Kyle D Brizendine
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, THT 229, 1900 University Boulevard, Birmingham, AL, 35294 0006, USA
    Curr Infect Dis Rep 12:299-305. 2010
    ..Future research targeting this population may further inform recommendations...
  27. pmc Epidemiology of Aspergillus terreus at a university hospital
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama 35294 0006, USA
    J Clin Microbiol 41:5525-9. 2003
    ..Further surveillance of A. terreus may better define epidemiology and determine whether this organism is becoming more frequent in relation to other Aspergillus species...
  28. ncbi request reprint Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features
    John W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, 35294 0006, USA
    Clin Transplant 16:419-24. 2002
    ..Although fungal brain abscess is an uncommon disease in this population, outcome was poor, suggesting that early recognition of this disease might be helpful...
  29. doi request reprint Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease
    J W Baddley
    Division of Infectious Diseases and International Health, Department of Medicine, University of Alabama at Birmingham, 1900 University Boulevard, 229 Tinsley Harrison Tower, Birmingham, AL 35294 0006, USA
    Eur J Clin Microbiol Infect Dis 27:937-43. 2008
    ..These findings may be helpful in the evaluation of HIV-negative patients with pulmonary cryptococcosis with regard to the need for lumbar puncture or to search for disseminated disease...
  30. ncbi request reprint Invasive mold infections in allogeneic bone marrow transplant recipients
    J W Baddley
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    Clin Infect Dis 32:1319-24. 2001
    ..These observations suggest that early identification of high-risk patients and better approaches to prevention should be explored, to reduce incidence and severity of disease in this population...
  31. ncbi request reprint Surgical treatment of multiple skull abscesses associated with coccidioidomycosis
    J W Baddley
    Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, 35294 0006, USA
    Mycoses 47:69-71. 2004
    ..Despite prolonged aggressive medical management, these lesions failed to resolve until they were surgically drained...
  32. pmc Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria
    Brahm H Segal
    Department of Medicine, Roswell Park Cancer Institute, Buffalo, New York 14263, USA
    Clin Infect Dis 47:674-83. 2008
    ..We also discuss potential pitfalls in assessing outcome, such as conflicting clinical, radiological, and/or mycological data and gaps in knowledge...
  33. ncbi request reprint Viral latency--the papillomavirus model
    T R Broker
    Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, 35294-0005, USA
    Dev Biol (Basel) 106:443-51; discussion 452-3, 465-75. 2001
    ..Their prevalence elicits a caution that latent HPV DNA may be present in primary human epithelial tissues...
  34. doi request reprint Fatal Burkholderia gladioli infection misidentified as Empedobacter brevis in a lung transplant recipient with cystic fibrosis
    K D Brizendine
    Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA
    Transpl Infect Dis 14:E13-8. 2012
    ..gladioli, which include cases of pneumonia, tracheobronchitis, bacteremia, and abscesses, and demonstrate an all-cause 1-year mortality of approximately 23%, often after combined medical and surgical treatment...
  35. ncbi request reprint Blastomycosis: Gilchrist's disease revisited
    Peter G Pappas
    University of Alabama at Birmingham, Birmingham, Alabama, USA
    Curr Clin Top Infect Dis 22:61-77. 2002
  36. doi request reprint Blastomycosis of the central nervous system: a multicenter review of diagnosis and treatment in the modern era
    J Ryan Bariola
    Division of Infectious Diseases, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
    Clin Infect Dis 50:797-804. 2010
    ..Central nervous system (CNS) involvement with Blastomyces dermatitidis is an uncommon and potentially fatal complication of blastomycosis...
  37. ncbi request reprint Donor-related coccidioidomycosis in organ transplant recipients
    Patty W Wright
    University of Alabama at Birmingham, Birmingham, AL 35294 0006, USA
    Clin Infect Dis 37:1265-9. 2003
    ..immitis is endemic. Both subjects had received a transplanted organ from the same donor, an individual with unrecognized active coccidioidomycosis at the time of his death...
  38. doi request reprint Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america
    John R Perfect
    Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina 27710, USA
    Clin Infect Dis 50:291-322. 2010
    ..However, if the diagnosis is made early, if clinicians adhere to the basic principles of these guidelines, and if the underlying disease is controlled, then cryptococcosis can be managed successfully in the vast majority of patients...
  39. pmc Nonsporulating clinical isolate identified as Petromyces alliaceus (anamorph Aspergillus alliaceus) by morphological and sequence-based methods
    S Arunmozhi Balajee
    Mycotic Diseases Branch, Centers for Disease Control and Prevention, Mail stop G 11, 1600 Clifton Road, Atlanta, GA 30333, USA
    J Clin Microbiol 45:2701-3. 2007
    ..This rare Aspergillus sp. was recovered as the etiological agent of invasive pulmonary aspergillosis and had reduced in vitro susceptibilities to amphotericin B and caspofungin, which correlated with clinical failure of therapy...
  40. ncbi request reprint Anidulafungin versus fluconazole for invasive candidiasis
    Annette C Reboli
    University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School and Cooper University Hospital, Camden, NJ 08103, USA
    N Engl J Med 356:2472-82. 2007
    ..Anidulafungin, a new echinocandin, has potent activity against candida species. We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial of treatment for invasive candidiasis...
  41. pmc Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States
    Luis Ostrosky-Zeichner
    University of Texas Houston Medical School, Houston, Texas, USA
    Antimicrob Agents Chemother 47:3149-54. 2003
    ....
  42. doi request reprint Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitis
    Weerawat Manosuthi
    Department of Medicine, Bamrasnaradura Infectious Diseases Institute, Tiwanon Road, Nonthaburi 11000, Thailand
    Int J STD AIDS 19:268-71. 2008
    ..In resource-limited settings, the use of temporary external lumbar drainage is a safe and effective management strategy for intractable elevated ICP in HIV-infected patients with cryptococcal meningitis...
  43. pmc Fungemia caused by Zygoascus hellenicus in an allogeneic stem cell transplant recipient
    Mary E Brandt
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop G 11, Atlanta, GA 30333, USA
    J Clin Microbiol 42:3363-5. 2004
    ..The organism was misidentified by a commercial yeast identification system. This is the first reported case of human infection with this rare ascomycetous yeast...
  44. pmc Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) C
    Ben de Pauw
    Department of Blood Transfusion Service and Transplant Immunology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Clin Infect Dis 46:1813-21. 2008
    ..Clarity and uniformity in defining these infections are important factors in improving the quality of clinical studies. A standard set of definitions strengthens the consistency and reproducibility of such studies...
  45. ncbi request reprint Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America
    Stanley W Chapman
    University of Mississippi Medical Center, Jackson, USA
    Clin Infect Dis 46:1801-12. 2008
    ..New information, based on publications between 2000 and 2006, is incorporated in this guideline document, and recommendations for treating children with blastomycosis have been noted...
  46. ncbi request reprint Managing cryptococcal meningitis is about handling the pressure
    Peter G Pappas
    Clin Infect Dis 40:480-2. 2005
  47. ncbi request reprint Invasive candidiasis in the intensive care unit
    Luis Ostrosky-Zeichner
    University of Texas Health Science Center at Houston, TX, USA
    Crit Care Med 34:857-63. 2006
    ....
  48. pmc Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
    Robert A Larsen
    Department of Medicine Infectious Diseases, 2020 Zonal Ave, IRD Room 632, MC 9520, University of Southern California, Los Angeles, CA 90033, USA
    Antimicrob Agents Chemother 49:952-8. 2005
    ..The half-life of MAb 18B7 in serum was approximately 53 h, while the MAb was undetectable in the cerebrospinal fluid of all patients. These data support the continued investigation of MAb 18B7 at a maximum single dose of 1.0 mg/kg...
  49. ncbi request reprint Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America
    Carol A Kauffman
    Infectious Diseases Section, Veterans Affairs Medical Center, University of Michigan Medical School, Ann Arbor, MI 48105, USA
    Clin Infect Dis 45:1255-65. 2007
    ..Recommendations are also provided for the treatment of sporotrichosis in pregnant women and in children...
  50. ncbi request reprint Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans
    Luis Ostrosky-Zeichner
    University of Texas Houston Medical School, Houston, TX 77030, USA
    Clin Infect Dis 41:654-9. 2005
    ..Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI)...
  51. doi request reprint Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis
    Douglas C Chang
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Control Hosp Epidemiol 29:25-30. 2008
    ....

Research Grants2

  1. Transplant Associated Infection Surveillance Network
    Peter Pappas; Fiscal Year: 2007
    ..Finally, the establishment of a bank will be invaluable in the development and validation of newer diagnostic assays. ..